Kidney Cancer Clinical Trial
Evaluating Renal Masses Using Ultrasound Intravenous Microbubble Contrast
Summary
The purpose of this study is to evaluate the blood flow in kidney masses by using ultrasound microbubble contrast material, and to see if results from ultrasound contrast studies can predict if a kidney mass is benign or malignant. Patterns of blood flow in the kidney mass will be examined to see if:
benign kidney masses can be distinguished from kidney cancers and
if slow growing, lower risk cancers have different blood flow compared to clear cell cancer which is the most common type of kidney cancer.
Eligibility Criteria
Inclusion Criteria:
Any adult patient who is planned or scheduled for surgical excision or biopsy of a solid or complex cystic renal mass would be eligible for the study
Histology of the renal mass must be unknown at the time of enrollment
Patients who have renal masses that are evident on conventional US imaging
Patients will have a correlative abdominal CT and/or MRI
Exclusion Criteria:
Patients with any history of cardiac shunts.
Patients with history of pulmonary hypertension or unstable cardiopulmonary conditions, including patients on mechanical ventilation.
Patients without peripheral IV access
Pregnant patients and children
Patients with any known contrast allergies, allergy to perflutren, or any components of Definity or microbubble contrast
Patients who have renal masses that are not evident on conventional US imaging
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
New York New York, 10065, United States
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.